US Stock MarketDetailed Quotes

NKTR Nektar Therapeutics

Watchlist
  • 0.9826
  • +0.0908+10.18%
Close Feb 14 16:00 ET
  • 1.0000
  • +0.0174+1.77%
Post 20:01 ET
181.25MMarket Cap-1.17P/E (TTM)

Nektar Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Nektar Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 22.390M--
--2024/Q4-- / 36.654M--
Nov 7, 20242024/Q324.124M / 18.280M--
Aug 8, 20242024/Q223.489M / 17.545M--
May 9, 20242024/Q121.639M / 15.342M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 22.390M--
--2024/Q4-- / 36.654M--
Nov 7, 20242024/Q324.124M / 18.280M--
Aug 8, 20242024/Q223.489M / 17.545M--
May 9, 20242024/Q121.639M / 15.342M--

Unlock Free Earnings Estimates

Nektar Therapeutics Earnings Reports

  • Nektar Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 8, 2024 12:20 ET

  • Nektar Therapeutics | 8-K: Nektar Therapeutics Reports Third Quarter 2024 Financial Results

    Nov 7, 2024 16:39 ET

  • Nektar Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 9, 2024 14:07 ET

  • Nektar Therapeutics | 8-K: Nektar Therapeutics Reports Second Quarter 2024 Financial Results

    Aug 8, 2024 16:27 ET

    • Read more

    Trending Stocks

    Top Gaining Chinese Stocks Top Gaining Chinese Stocks
    No. Symbol % Chg
    PILOT
    831175
    +30.00%
    XINGANJIANG
    873167
    +29.99%
    Beijing Highlander Digital Technology
    300065
    +20.05%
    4
    Hangzhou Gaoxin Materials Technology
    300478
    +20.02%
    5
    Shijihengtong Technology
    301428
    +20.01%
    Log In for the Full List
    Unlock Now
    Investment Course
    Top 5 Industries for Stock Trading under Trump's Second Term
    Stocks & Industries to Watch Under Trump's Second Presidency
    With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
    Discussing
    Major earnings are approaching! What's ahead for Chinese stocks in 2025?
    Recently, institutions such as Goldman Sachs, Morgan Stanley, and Appaloosa LP have spoken positively about Chinese assets. 🎙️Discussion: 1 Show More
    China's asset revaluation sparks debate: What are mooers buying?
    Monetary Policy: Navigating the Fed's Rate Cut Cycle
    Changing Fed policy is altering the market math for investors.